Literature DB >> 23182533

Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child.

Markus J Kemper, Changli Wei, Jochen Reiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23182533     DOI： 10.1053/j.ajkd.2012.10.011

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  10 in total

1.  Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children.

Authors:  Zhaoyang Peng; Jianhua Mao; Xuejun Chen; Fengqing Cai; Weizhong Gu; Haidong Fu; Huijun Shen; Jingjing Wang; Xia Jin; Xiujuan Zhu; Aimin Liu; Qiang Shu; Lizhong Du
Journal:  Pediatr Nephrol       Date:  2014-07-18       Impact factor: 3.714

Review 2.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

3.  Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.

Authors:  Nada Alachkar; Changli Wei; Lois J Arend; Annette M Jackson; Lorraine C Racusen; Alessia Fornoni; George Burke; Hamid Rabb; Kavita Kakkad; Jochen Reiser; Michelle M Estrella
Journal:  Transplantation       Date:  2013-10-15       Impact factor: 4.939

4.  Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis.

Authors:  Pingping Sun; Lei Yu; Jing Huang; Suxia Wang; Wanzhong Zou; Li Yang; Gang Liu
Journal:  Kidney Dis (Basel)       Date:  2019-05-27

Review 5.  Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines.

Authors:  Kimberly Blom; Ayodele Odutayo; Kate Bramham; Michelle A Hladunewich
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

6.  Has the circulating permeability factor in primary FSGS been found?

Authors:  J Ashley Jefferson; Stuart J Shankland
Journal:  Kidney Int       Date:  2013-08       Impact factor: 10.612

7.  Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin.

Authors:  Michelle A Hladunewich; Dan Cattran; Sanjeev M Sethi; Salim S Hayek; Jing Li; Changli Wei; Sarah I Mullin; Heather N Reich; Jochen Reiser; Fernando C Fervenza
Journal:  Kidney Int Rep       Date:  2021-10-30

8.  Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.

Authors:  Jing Huang; Gang Liu; Yi-miao Zhang; Zhao Cui; Fang Wang; Xiao-jing Liu; Rong Chu; Ming-hui Zhao
Journal:  BMC Med       Date:  2014-05-20       Impact factor: 8.775

Review 9.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

10.  Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR.

Authors:  Shirley Shuster; Ghada Ankawi; Christoph Licht; Jochen Reiser; Xuexiang Wang; Changli Wei; David Chitayat; Michelle Hladunewich
Journal:  J Clin Med       Date:  2018-10-04       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.